Affinity Wealth Management’s DexCom DXCM Stock Holding History

Affinity Wealth Management’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-23,310	Closed	-$3M	–	100
2023 Q2	$3M	Buy	+23,310	New	+$2.82M	0.69%	39

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Affinity Wealth Management's DXCM Position: Q3 2023 in Review

Affinity Wealth Management sold out of DexCom (DXCM) in Q3 2023, closing a stake of 23,310 shares — an estimated $3M sold.

Affinity Wealth Management first reported a position in DXCM in Q2 2023 and held it in 1 quarter. The position peaked at $3M in Q2 2023. 902 funds tracked by Wall St. Rank hold DXCM as of Q3 2023.

Affinity Wealth Management reported no remaining DexCom position as of Q3 2023 after selling out during the quarter.
Affinity Wealth Management sold 23,310 DexCom shares in Q3 2023, an estimated $3M.
Affinity Wealth Management first reported a position in DexCom in Q2 2023 and held it in 1 quarter.
Affinity Wealth Management's DexCom position peaked at $3M in Q2 2023.
902 funds tracked by Wall St. Rank held DexCom as of Q3 2023.

Based on Affinity Wealth Management's 13F filing for Q3 2023, filed 24 Oct 2023.